Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2022 Feb 8;3(3):371. doi: 10.1038/s43018-022-00342-9

Author Correction: The immuno-oncological challenge of COVID-19

Lisa Derosa 1,2,3, Cléa Melenotte 1,2,4,5, Franck Griscelli 1,6, Bertrand Gachot 1,7, Aurélien Marabelle 1,2,3, Guido Kroemer 8,9,10,11,12, Laurence Zitvogel 1,2,3,12,13,
PMCID: PMC9106799  PMID: 35136234

Correction to: Nature Cancer 10.1038/s43018-020-00122-3, published online 2 October 2020.

In the version of this article initially published, there was an error in Table 3. In the row for Oseltamivir, in the fifth column “Antitumor effect in vivo,” the text now reading “Pro-tumorigenic effects in mice: Increased aggressiveness of canine mammary tumor xenografts276” initially appeared as “In canines and mice: Increase mammary tumor aggressiveness276.” The change has been made to the HTML and PDF versions of the article.


Articles from Nature Cancer are provided here courtesy of Nature Publishing Group

RESOURCES